When are expensive drugs good value for money?

被引：0

作者：

Riesberg, A

Velasco-Garrido, M

Weinbrenner, S

Gericke, CA

Busse, R

机构：

[1] Tech Univ Berlin, Fachgebiet Management Gesundheitswesen, D-10623 Berlin, Germany

[2] European Observ Hlth Syst & Policies, London, England

来源：

INTERNIST | 2004年 / 45卷 / 10期

关键词：

drug therapy; treatment outcome; cost-analysis; cost control; evaluation studies;

D O I：

10.1007/s00108-004-1238-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Expensive drugs are good value for money if they are effective and safe, and if they have a better cost-effectiveness ratio than the standard therapy. In this article, an overview of commonly used methods, sources and functions of health economic evaluation is presented and illustrated using clinical examples to facilitate interpretation of the health economic information.

引用

页码：1189 / +

页数：6

共 30 条

[1]

[Anonymous], 2002, JAMA

[2]

*AUSTR DEP HLTH AG, 2002, GUID PHARM IND PREPR

[3] Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies [J].

Beijer, HJM ;

de Blaey, CJ .

PHARMACY WORLD & SCIENCE, 2002, 24 (02) :46-54

[4]

BREYER F, 2002, GESUNDHEITSOKONOMIE, P421

[5] Best practice in undertaking and reporting health technology assessments -: Working group 4 report [J].

Busse, R ;

Orvain, J ;

Velasco, M ;

Perleth, M ;

Drummond, M ;

Gürtner, F ;

Jorgensen, T ;

Jovell, A ;

Malone, J ;

Rüther, A ;

Wild, C .

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (02) :361-422

[6]

BUSSE R, 2004, IN PRESS GESUNDHEITS

[7]

DIETRICH ES, 2003, OKONOMISCHE ASPEKTE

[8] Users' guides to the medical literature .13. How to use an article on economic analysts of clinical practice .A. Are the results of the study valid? [J].

Drummond, MF ;

Richardson, WS ;

OBrien, BJ ;

Levine, M ;

Heyland, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1552-1557

[9] Cost effectiveness analysis and the consistency of decision making - Evidence from pharmaceutical reimbursement in Australia (1991 to 1996) [J].

George, B ;

Harris, A ;

Mitchell, A .

PHARMACOECONOMICS, 2001, 19 (11) :1103-1109

[10]

GERICKE C, 2003, ARZNEIMITTELFORSCH D, V53, P918

← 1 2 3 →